Insulin and risk of cardiovascular disease: A meta-analysis

Circulation

Volumn 97, Issue 10, 1998, Pages 996-1001

  Ruige, J B ^a,b   Assendelft, W J J ^a   Dekker, J M ^a   Kostense, P J ^a   Heine, R J ^a   Bouter, L M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cardiovascular diseases; Epidemiology; Follow up studies; Insulin; Meta analysis

Indexed keywords

INSULIN;

ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; DEATH; ELECTROCARDIOGRAPHY; ETHNIC DIFFERENCE; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 0032539895     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.10.996     Document Type: Article

References (48)

1. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care. 1995;18:1299-1304.
2. Jarrett RJ. Is insulin atherogenic? Diabetologia. 1988;31:71-75.
3. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care. 1990;13:631-654.
4. Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia. 1994;37:953-955.
5. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. 1994;37:948-952.
6. Taegtmeyer H. Insulin resistance and atherosclerosis: common roots for two common diseases? Circulation. 1996;93:1777-1779.
7. Stern MP. Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents? Ann Intern Med. 1996;124:110-116.
8. Reaven GM, Chen YD. Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation. 1996;93:1780-1783.
9. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809-1817.
10. McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care. 1995;18:1294-1298.
11. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
12. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. London, UK: Chapman and Hall; 1989.
13. Mooy JM, Grootenhuis PA, Vries HD, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ. Intra-individual variation of glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetohgia. 1996;39:298-305.
14. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:831-837.
15. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
16. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
17. Olkin I. A critical look at some popular meta-analytic methods. Am J Epidemiol. 1994;140:297-299.
18. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4:218-228.
19. Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology. 1995;6:137-141.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
21. Greenland S. A critical look at some popular meta-analytic methods. Am J Epidemiol. 1994;140:290-296.
22. Collins VR, Dowse GK, Zimmet PZ, Tuomilehto J, Alberti KG, Gareeboo H, Nan L. Serum insulin and ECG abnormalities suggesting coronary heart disease in the populations of Mauritius and Nauru: cross-sectional and longitudinal associations. J Clin Epidemiol. 1993;46:1373-1393.
23. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9.5-year follow-up of the Helsinki policemen study population. Acta Med Scand Suppl. 1985;701:38-52.
24. Fontbonne A, Tchobroutsky G, Eschwège E, Richards JL, Claude JR, Rosselin GE. Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker dun hypertension or abnormal glucose tolerance in overweight males: me Paris Prospective Study. Int J Obes. 1988;12:557-565.
25. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwège E. Hyperinsulinaemia as a predictor of coro- nary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:356-361.
26. Liu QZ, Knowler WC, Nelson RG, Saad MF, Charles MA. Liebow IM, Bennet PH. Pettitt DJ. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians, Diabetes. 1992;41:1141-1150.
27. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol. 1996;144:224-234.
28. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
29. Welin L, Eriksson H, Larsson B, Ohlson LO, Svärdsudd K, Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men: the Study of Men Born in 1913. Diabetologia. 1992;35:766-770.
30. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersma RA. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61-69.
31. Rewers M, Shetterly SM, Baxter J, Hamman RF. Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): the San Luis Valley Diabetes study. Circulation. 1992;85:865. Abstract.
32. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol. 1994;140:857-869.
33. Yarnell JW, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J. 1994;71:293-296.
34. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994;4:40-45.
35. Ducimetiere P, Eschwège E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
36. Balkau B, Eschwège E, Fontbonne A, Claude JR, Warnet JM. Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects. Diabetologia. 1992;35:39-44.
37. Cullen K, Stenhouse NS, Wearne KL, Welbom TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia, 13-year study. J Chronic Dis. 1983;36:371-377.
38. Eschwège E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res Suppl. 1985;15:41-46.
39. Moller LF, Jespersen J. Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk. 1995;2:235-240.
40. Welborn TA, Knuiman MW, Ward N, Whittall DE. Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Proct. 1994;26:51-59.
41. Berlin JA. Benefits of heterogeneity in meta-analysis of data from epidemiologic studies. Am J Epidemiol. 1995;142:383-387.
42. Nordestgaard BG, Agerholm-Larsen B, Stender S. Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits. Diabetologia. 1997;40:512-520.
43. Nelson RG, Sievers ML, Knowler WC, Swinburn BA, Pettitt DJ, Saad MF, Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation. 1990;81:987-995.
44. Nordt TK, Sawa H, Fujii S, Sobel BE. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation. 1995;91:764-770.
45. Haffner SM. The insulin resistance syndrome revisited. Diabetes Care. 1996;19:275-277.
46. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Boston, Mass: Harvard University Press; 1984.
47. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology. 1993;4:366-374.
48. Blair A, Burg J, Foran J, Gibb H, Greenland S, Morris R, Raabe G, Savitz D, Teta J, Wartenberg D, Wong O, Zimmerman R. Guidelines for application of meta-analysis in environmental epidemiology. Regul Toxicol Pharmacol. 1995;22:189-197.